VRTX
vs
BMY
VRTX
BMY
Over the past 12 months, VRTX has underperformed BMY, delivering a return of +3% compared to the BMY's +8% growth.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
VRTX
BMY
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
470.29
USD
|
|||||
|
Bristol-Myers Squibb Co
NYSE:BMY
|
60.52
USD
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
VRTX, BMY
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
Vertex Pharmaceuticals Inc
Revenue
|
|||||||||||
|
Bristol-Myers Squibb Co
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
VRTX, BMY
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
|||||||||
|
Bristol-Myers Squibb Co
NYSE:BMY
|
|||||||||
Compare company's free cash flow with its competitors.
Gross Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Vertex Pharmaceuticals Inc | ||||
|
Bristol-Myers Squibb Co | ||||
Operating Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Vertex Pharmaceuticals Inc | ||||
|
Bristol-Myers Squibb Co | ||||
Net Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Vertex Pharmaceuticals Inc | ||||
|
Bristol-Myers Squibb Co | ||||
FCF Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Vertex Pharmaceuticals Inc | ||||
|
Bristol-Myers Squibb Co | ||||
ROE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Vertex Pharmaceuticals Inc | ||||
|
Bristol-Myers Squibb Co | ||||
ROA
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Vertex Pharmaceuticals Inc | ||||
|
Bristol-Myers Squibb Co | ||||
ROIC
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Vertex Pharmaceuticals Inc | ||||
|
Bristol-Myers Squibb Co | ||||
ROCE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Vertex Pharmaceuticals Inc | ||||
|
Bristol-Myers Squibb Co | ||||
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
VRTX, BMY
Performance Gap
VRTX, BMY
Performance By Year
VRTX, BMY
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
| FR |
|
Pharnext SCA
OTC:PNEXF
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
|
| US |
S
|
Seagen Inc
F:SGT
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|